Učitavanje...
The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
BACKGROUND: Rapastinel (GLYX-13) is a NMDA receptor modulator with glycine-site partial agonist properties. It is a robust cognitive enhancer and shows rapid and long-lasting antidepressant properties in both animal models and in humans. METHODS: Rapastinel was derived from a monoclonal antibody, B6...
Spremljeno u:
| Izdano u: | Curr Neuropharmacol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bentham Science Publishers
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327451/ https://ncbi.nlm.nih.gov/pubmed/26997507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666160321122703 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|